长期使用他类药物而没有传统风险因素的狂肌病:一个病例报告
Hiroyuki Naritaka1, Yoshitaka Aoki1, Yukako Obata1
1Department of Anesthesiology and Intensive Care Medicine, Hamamatsu University School of Medicine, Hamamatsu, JPN.
Cureus
|October 30, 2023
概括
本案例研究详细介绍了长期使用他类药物治疗的患者罕见的一例rhabdomyolysis. 它强调要考虑这种严重的疾病,即使没有典型的危险因素.
科学领域:
- 内部医学 内部医学
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 类药物广泛用于高脂血症管理.
- 拉布地质溶解是已知的,尽管很少见的,他类药物治疗的不良影响.
- 鉴定他类药物诱导的狂宫痛解的危险因素对于患者的安全至关重要.
研究的目的:
- 报告长期使用他类药物治疗的患者罕见的一例rhabdomyolysis.
- 突出了在没有常见风险因素的情况下,体溶解的潜力.
- 为了强调对这种不良事件的临床警的重要性.
主要方法:
- 一个64岁的男性患者的病例报告.
- 对临床表现,实验室值和治疗过程的审查.
- 对拉布多米解的潜在促成因素的分析.
主要成果:
- 尽管没有明显的传统风险因素,但该患者患上了骨髓溶解和急性功能衰竭.
- 停止他类药物治疗和支持性护理导致功能和肌酸酶水平的稳定.
- 血液透析不需要,患者在稳定的状态下出院.
结论:
- 在接受他类药物治疗的患者出现相关症状时,即使没有典型的危险因素,也应该考虑进行狂肌溶解.
- 早期识别和管理是有利结果的关键.
- 这一案例强调了对他类药物相关肌肉病的持续认识的需要.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
676
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
676
Nephrotic Syndrome I : Introduction
9
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
9
Chronic Kidney Disease II: Clinical Manifestations
12
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
12
Nephrotic Syndrome II : Assessment and Medical Management
8
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8
Chronic Kidney Disease III: Interprofessional Care
21
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
21
Chronic Kidney Disease I: Introduction
18
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
18


